Contracts & Pricing July 24, 2023 340B Contract Pharmacy Restrictions, Legislators on PBMs, and IRA Lawsuits 5 Minute Read Updates on 340B Contract Pharmacy Restrictions from Pharma Manufacturers, Legislators Shift Focus onto PBMs, and IRA Lawsuits.
Contracts & Pricing June 28, 2023 IRA Updates, The Rise of Medical Benefit Contracting, and New CMS... 8 Minute Read Updates on IRA Updates, The Rise of Medical Benefit Contracting, and the New CMS Proposed Rule.
Contracts & Pricing May 31, 2023 Puerto Rico Medicaid Drug Rebate Program Claims Administrator, TAA Compliance and... 3 Minute Read Updates on US Territory Enrollment Updates, Puerto Rico Medicaid Drug Rebate Program Claims Administrator, TAA Compliance and its Relevance to FSS Agreements, and State Price Transparency Reporting Updates.
Contracts & Pricing April 24, 2023 340B Contract Pharmacy Restrictions, M&A Funding in Biotech & FDA Accelerated... 6 Minute Read Updates on 340B Contract Pharmacy Restriction Updates, M&A and Venture Capital Funding in Biotech, and Stricter Accelerated Approval Criteria Proposed for FDA.
Contracts & Pricing March 29, 2023 Updates on MDRP NOTICE Release No. 117, Inflation Reduction Act Guidance... 5 Minute Read Updates on MDRP NOTICE Release No. 117, Inflation Reduction Act, and Operationalizing Medicare Inflationary Rebates.
Contracts & Pricing February 27, 2023 FDA Set to Apply Orphan-Drug Exclusivity, 2022 Employer Health Benefits Survey... 5 Minute Read Updates on two significant regulatory topics, including the FDA decision on orphan-drug exclusivity regulations and highlights from the Kaiser Family Foundation 2022 Employer Benefits Survey.
Contracts & Pricing January 31, 2023 Inflation Reduction Act Impact on R&D, OIG Studies on Average Sales... 6 Minute Read Updates on four significant regulatory topics, including the inflation reduction act impact on research and development, Office of Inspector General studies on Average Sales Price, and a shift of...
Contracts & Pricing December 20, 2022 Value-Based Purchasing, Interchangeability in Biosimilars, Year End 2022 Roundup 5 Minute Read Updates on two significant regulatory topics, including value-based purchasing, interchangeabilty with biosimilars, and an end of 2022 roundup.
Contracts & Pricing December 15, 2022 2022 Trends in State Pricing Transparency Reporting 3 Minute Read This is the first in a two-part blog series covering the ever-changing requirements by states as well as 2022 trends in Pricing Transparency Reporting.
